SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000929638-19-000598
Filing Date
2019-06-03
Accepted
2019-06-03 16:03:00
Documents
2
Group Members
AQUILA INVESTMENTS IVTYBOURNE CAPITAL MANAGEMENT LTDTYBOURNE KESARI LTDVISWANATHAN KRISHNAN

Document Format Files

Seq Description Document Type Size
1 schedule13d.htm SC 13D 102145
2 exhibit99.htm EX-99.1 8553
  Complete submission text file 0000929638-19-000598.txt   112540
Mailing Address 30/F, AIA CENTRAL 1 CONNAUGHT ROAD C HONG KONG K3 XXXXX
Business Address 30/F, AIA CENTRAL 1 CONNAUGHT ROAD C HONG KONG K3 XXXXX 852-3983-6869
TYBOURNE CAPITAL MANAGEMENT (HK) LTD (Filed by) CIK: 0001553936 (see all company filings)

IRS No.: 000000000 | State of Incorp.: K3 | Fiscal Year End: 1231
Type: SC 13D

Mailing Address B900 BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address B900 BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 011441223261503
BICYCLE THERAPEUTICS plc (Subject) CIK: 0001761612 (see all company filings)

IRS No.: 000000000
Type: SC 13D | Act: 34 | File No.: 005-91023 | Film No.: 19873266
SIC: 2834 Pharmaceutical Preparations